Award

Tonks honored for seminal work on protein tyrosine phosphatases

He won ASBMB's Stadtman Distinguished Scientist Award
Nathalie Gerassimov
April 01, 2019

Nicholas Tonks, the Caryl Boies professor of cancer research at Cold Spring Harbor Laboratory, has won the American Society for Biochemistry and Molecular Biology’s 2019 Earl and Thressa Stadtman Distinguished Scientist Award for his three decades of outstanding research in the field of protein tyrosine phosphatases, or PTPs, enzymes that regulate the signal transduction cascades of many cellular processes.

 

Nicholas Tonks

“I am honored to receive this award, which I hope will help to draw attention to all of the outstanding research being performed on the PTP family of enzymes. These are exciting times as new biological functions and links to disease are being defined for the PTPs. Hopefully, we will soon witness the first drugs that target these enzymes for the treatment of major human diseases.”

— Nicholas Tonks

Bruce Stillman, president and CEO of Cold Spring Harbor Laboratory, nominated Tonks, calling him “a pioneer and a consistent leader in the field.” David Barford of the Medical Research Council Laboratory of Molecular Biology wrote in support of the nomination, “Tonks is a member of a select group of scientists responsible for establishing and developing a new research field of immense importance and significance.”

Tonks received a bachelor’s degree in biochemistry from Oxford University in 1981 and a Ph.D. from the University of Dundee in 1985, working with Sir Philip Cohen.

Little was known about tyrosine dephosphorylation when Tonks started his postdoctoral work with Edmond Fischer at the University of Washington, where Tonks discovered and characterized the first PTP, known as PTP1B. Tonks and collaborators also showed that the membrane-spanning lymphocyte common antigen CD45 was a PTP, advancing the field of immunology.

After Tonks joined the faculty at Cold Spring Harbor in 1990, his lab showed that PTEN, the major tumor suppressor protein mutated in many cancers, had PTP activity, and he characterized further the importance of its lipid and protein phosphatase function. Throughout his independent career, Tonks has advanced the PTP field in diverse cellular pathways.

His lab helped lay the groundwork for PTP1B as a therapeutic target for a range of human diseases. In collaboration with others, they determined the crystal structure of PTP1B, deciphering the mechanisms of PTP catalysis and substrate recognition, and then designed substrate-trapping mutants that other researchers used to identify physiological PTP substrates.

In their second decade, Tonks’ team discovered how PTP1B is regulated: Hydrogen sulfide, a gaseous signaling molecule with membrane permeability, regulates PTP function as part of the unfolded protein response to endoplasmic reticulum stress, an essential process implicated in many diseases. They also discovered that PTPs can be inactivated reversibly by oxidation and developed methods to assay PTP redox state. This mechanism plays a role in insulin signaling, providing a therapeutic target for diabetes.

Tonks has pursued the therapeutic potential of his discoveries. His lab showed that small molecule inhibitors of PTP1B could have therapeutic use for Rett syndrome, and he led an early-stage human trial to show that PTP1B allosteric inhibitor MSI-1436 (trodusquemine) is a therapeutic target for HER2-positive breast cancer.

“Nick Tonks has been a major figure in biochemistry and signal transduction for nearly 30 years,” Benjamin Neel of New York University wrote in a letter supporting the award nomination. “He shows no sign of slowing down, and indeed, his most important work may yet be to come.”

Nathalie Gerassimov

Nathalie Gerassimov is a postdoctoral researcher at the Carnegie Institution of Washington department of embryology.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Herbert Tabor 1918 – 2020
Retrospective

Herbert Tabor 1918 – 2020

September 24, 2020

F. Peter Guengerich remembers the contributions of the longtime editor of the Journal of Biological Chemistry who died in August.

ASBMB welcomes new members
Member News

ASBMB welcomes new members

September 21, 2020

The American Society for Biochemistry and Molecular biology welcomed more than 60 new members in April.

It all comes down to where we place our bets
Interview

It all comes down to where we place our bets

September 18, 2020

Mark Harpel works in a research unit at GlaxoSmithKline that helps choose the most promising targets for new drug development.

Understanding the impact of Type 1 diabetes susceptibility genes
Research Spotlight

Understanding the impact of Type 1 diabetes susceptibility genes

September 17, 2020

Starting in eighth grade, a series of mentors who saw something special in Sharifa Love–Rutledge helped her stay on the path to being a researcher — and becoming a mentor to others.

Cell biology, microbiology societies present awards
Member News

Cell biology, microbiology societies present awards

September 14, 2020

Honorees include ASBMB members Joann Trejo, James Olzmann, Steven Farber, Sue Wickner and Bernard Moss.

Virtual volunteering in the land of lakes and volcanoes
Outreach

Virtual volunteering in the land of lakes and volcanoes

September 09, 2020

Brandon Roy encourages other scientists to teach students in Nicaragua through the Outreach 360 program